Novo Nordisk A/S stock price
NVO
#59

$45.00
  

1.78%

Novo Nordisk A/S Info

Market cap
$199.43B

1.78%

Daily Volume
$417.94M
Asset type
Stocks
Employees
78387
Founded
Dec 21, 1923
Primary exchange
New York Stock Exchange
CIK number
0000353278

Tokenized Stock Data

Avg. Tokenized Price
$45.84
Price Difference
+$0.8458(+1.88%)
Tokenized Mkt Cap
$3.66M

0.62%

Tokenized Vol (24h)
$991.3K

3.09%

Contracts
Explorers
NVO to USD converter
NVO
USD
Price Performance
Low
$43.93
High
$45.24

Loading Data

Please wait a moment.

Novo Nordisk A/S community

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Price Live Data

The current price of Novo Nordisk A/S in the market is $45, with a 24-hour trading volume of $417.94M. The asset's market cap is $199.43B, after moving 1.78% in the last day.

Tokenized Novo Nordisk A/S is trading at $45.84, with a tokenized market cap of $3.66M and a 24-hour trading volume of $991.3K. The tokenized asset has moved 0.62% in the past 24 hours.